Contact
Please use this form to send email to PR contact of this press release:
Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22
TO:
Please use this form to send email to PR contact of this press release:
Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22
TO: